• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴幼儿中的甲氟喹

Mefloquine in infants and young children.

作者信息

Luxemburger C, Price R N, Nosten F, Ter Kuile F O, Chongsuphajaisiddhi T, White N J

机构信息

Shoklo Malaria Research Unit, Mae Sod, Thailand.

出版信息

Ann Trop Paediatr. 1996 Dec;16(4):281-6. doi: 10.1080/02724936.1996.11747839.

DOI:10.1080/02724936.1996.11747839
PMID:8985524
Abstract

In an area where multi-drug resistance in Plasmodium falciparum is a particular problem, more than 500 children under 5 years of age weighing > 5 kg were treated with mefloquine, either alone or combined with an artemisinin derivative, and followed up for a minimum of 28 days. The principal adverse effect was vomiting and this was associated with reduced efficacy of treatment (even when treatment was repeated). Later adverse effects occurred less frequently than in adults. There was no serious toxicity and, in particular, there were no neuropsychiatric side-effects. The high dose of mefloquine (25 mg/kg) required in this area is well tolerated by young children. It should be given in a divided dose of 15 mg/kg initially, followed by 10 mg/kg > or = 12 hours later.

摘要

在一个恶性疟原虫多重耐药问题尤为突出的地区,500多名体重超过5千克的5岁以下儿童接受了甲氟喹治疗,治疗方式为单独使用甲氟喹或与青蒿素衍生物联合使用,并进行了至少28天的随访。主要不良反应是呕吐,且这与治疗效果降低有关(即使重复治疗时也是如此)。后期不良反应的发生频率低于成人。未出现严重毒性,尤其是未出现神经精神方面的副作用。该地区所需的高剂量甲氟喹(25毫克/千克)幼儿耐受性良好。应先给予15毫克/千克的分次剂量,12小时及以上后再给予10毫克/千克。

相似文献

1
Mefloquine in infants and young children.婴幼儿中的甲氟喹
Ann Trop Paediatr. 1996 Dec;16(4):281-6. doi: 10.1080/02724936.1996.11747839.
2
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.在泰国进行的一项随机双盲研究表明,通过预包装泡罩同时给予青蒿琥酯和甲氟喹三天,对于单纯性急性恶性疟原虫疟疾的治疗效果和耐受性与标准序贯治疗相当。
Am J Trop Med Hyg. 2002 Nov;67(5):465-72. doi: 10.4269/ajtmh.2002.67.465.
3
Mefloquine for uncomplicated Plasmodium falciparum malaria in children.甲氟喹治疗儿童无并发症恶性疟原虫疟疾。
Pediatr Infect Dis J. 2011 Oct;30(10):883-6. doi: 10.1097/INF.0b013e31821dc96f.
4
Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.蒿甲醚与甲氟喹治疗急性非复杂性恶性疟的比较。
Lancet. 1992 Nov 21;340(8830):1245-8. doi: 10.1016/0140-6736(92)92947-e.
5
High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.高剂量甲氟喹治疗耐多药恶性疟
J Infect Dis. 1992 Dec;166(6):1393-400. doi: 10.1093/infdis/166.6.1393.
6
[Tolerance and efficacy of mefloquine as the first line treatment of uncomplicated P. falciparum malaria in children].[甲氟喹作为儿童单纯性恶性疟原虫疟疾一线治疗药物的耐受性和疗效]
Pathol Biol (Paris). 2008 Feb;56(1):21-8. doi: 10.1016/j.patbio.2007.09.003. Epub 2008 Jan 4.
7
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.在泰国,对作为分开片剂的甲氟喹-青蒿琥酯与一种新的复方制剂治疗非复杂性多重耐药恶性疟进行的开放标签随机对照试验。
Trop Med Int Health. 2006 Nov;11(11):1653-60. doi: 10.1111/j.1365-3156.2006.01724.x.
8
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.甲氟喹治疗急性恶性疟:3673例患者非严重不良反应的前瞻性研究。
Bull World Health Organ. 1995;73(5):631-42.
9
Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children.蒿甲醚与甲氟喹治疗儿童单纯性恶性疟原虫高疟原虫血症的开放对比研究。
Ann Trop Paediatr. 1996 Mar;16(1):5-9. doi: 10.1080/02724936.1996.11747797.
10
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.接受青蒿素衍生物治疗的急性恶性疟患者的不良反应。
Am J Trop Med Hyg. 1999 Apr;60(4):547-55. doi: 10.4269/ajtmh.1999.60.547.

引用本文的文献

1
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.急性无并发症恶性疟原虫疟疾的血液学后果:全球抗疟网个体化患者数据分析的 pooled 分析。
BMC Med. 2022 Mar 7;20(1):85. doi: 10.1186/s12916-022-02265-9.
2
SERCAP: is the perfect the enemy of the good?SERCAP:“至善”是否会成为“至美”的敌人?
Malar J. 2021 Jun 24;20(1):281. doi: 10.1186/s12936-021-03821-z.
3
STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.
关于儿科旅行者的声明:热带医学与旅行咨询委员会
Can Commun Dis Rep. 2010 Jun 10;36(ACS-3):1-31. doi: 10.14745/ccdr.v36i00a03.
4
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.青蒿琥酯-甲氟喹固定剂量复方治疗非洲儿童无并发症恶性疟原虫疟疾的群体药代动力学和药效学。
Malar J. 2019 Apr 18;18(1):139. doi: 10.1186/s12936-019-2754-6.
5
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.乌干达和肯尼亚5岁以下儿童重度贫血出院后管理中每月使用双氢青蒿素-哌喹进行疟疾化学预防:一项多中心、双臂、随机、安慰剂对照、优效性试验的研究方案
Trials. 2018 Nov 6;19(1):610. doi: 10.1186/s13063-018-2972-1.
6
Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children.开发一种基于生理学的甲氟喹药代动力学模型,并将其与临床效果模型一起用于选择预防白人儿童疟疾的最佳剂量。
Br J Clin Pharmacol. 2019 Jan;85(1):100-113. doi: 10.1111/bcp.13764. Epub 2018 Nov 5.
7
Summary of recommendations for the diagnosis and treatment of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).热带医学与旅行咨询委员会(CATMAT)关于疟疾诊断与治疗的建议摘要。
Can Commun Dis Rep. 2014 Apr 3;40(7):133-143. doi: 10.14745/ccdr.v40i07a02.
8
Summary of recommendations on malaria issues in special hosts.关于特殊宿主中疟疾问题的建议总结。
Can Commun Dis Rep. 2014 May 15;40(10):178-191. doi: 10.14745/ccdr.v40i10a02.
9
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.以青蒿素为基础的联合疗法治疗无并发症间日疟原虫疟疾。
Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD008492. doi: 10.1002/14651858.CD008492.pub3.
10
A prospective study of adverse drug reactions to artemisinin-based combination therapy in a tertiary care hospital in India.一项在印度一家三级保健医院进行的青蒿素类复方疗法药物不良反应的前瞻性研究。
Indian J Pharmacol. 2012 Mar;44(2):257-60. doi: 10.4103/0253-7613.93863.